Viral cirrhosis: an overview of haemostatic alterations and clinical consequences

Francesca Romana Ponziani1, Valerio De Stefano, Antonio Gasbarrini

  • 1Department of Internal Medicine and Gastroentrology, Catholic University - Rome.

Insights

Viral hepatitis causes cirrhosis, leading to complex hemostatic (blood clotting) imbalances. This review examines altered blood clotting, bleeding, and thrombosis in cirrhosis patients, highlighting diagnostic challenges.

Area of Science:

  • Hepatology
  • Hematology
  • Internal Medicine

Background:

  • Viral hepatitis is a leading cause of cirrhosis and liver cancer globally.
  • Cirrhosis leads to liver dysfunction and portal hypertension, presenting life-threatening complications.
  • Altered hemostatic balance in cirrhosis complicates patient management, risking both bleeding and thrombosis.

Purpose of the Study:

  • To review the principal aspects of procoagulant, anticoagulant, and fibrinolytic capacity in cirrhotic patients.
  • To analyze the complex pathophysiological mechanisms of bleeding and thrombosis in cirrhosis.
  • To discuss the limitations of current laboratory investigations in assessing hemostasis in cirrhosis.

Main Methods:

  • Literature review of studies on hemostasis in liver cirrhosis.
  • Analysis of procoagulant, anticoagulant, and fibrinolytic systems in cirrhotic patients.
  • Discussion of pathophysiological mechanisms and clinical implications.

Main Results:

  • Hemostatic balance in cirrhotic patients is variably altered, not solely predisposing to bleeding.
  • Both bleeding manifestations and thrombosis can occur due to complex interactions of factors.
  • Current laboratory tests offer only a partial view of the in vivo hemostatic condition.

Conclusions:

  • Cirrhosis significantly impacts the entire hemostatic system, including clotting and anticoagulation.
  • Bleeding and thrombosis in cirrhosis result from intricate interactions, not just advanced liver disease.
  • Improved diagnostic tools are needed for a global overview of hemostasis in cirrhotic patients.

Related Concept Videos

Cirrhosis I: Introduction01:23

Cirrhosis I: Introduction

Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
Cirrhosis II: Pathophysiology01:24

Cirrhosis II: Pathophysiology

Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...
Esophageal Varices-I: Introduction01:24

Esophageal Varices-I: Introduction

Esophageal varices are dilated, tortuous veins which are found mainly in the submucosa of the lower esophagus but which may also appear higher up or extend into the stomach. They develop due to increased pressure in the portal venous system, often as a result of liver cirrhosis. This condition scars and damages the liver, impeding normal blood flow through the portal vein. To compensate, blood seeks alternative pathways, forming fragile new vessels (varices) in the esophagus and stomach. These...
Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Portal Hypertension01:22

Portal Hypertension

Portal hypertension is an increase in blood pressure within the portal venous system. Normally, this pressure is less than 5 mmHg. It is considered clinically significant when it rises above 10 mmHg. At this threshold, complications from altered blood flow and venous congestion emerge.EtiologyPortal hypertension arises from conditions that impede blood flow through the liver. The most common cause is cirrhosis, in which chronic liver injury leads to fibrotic scarring. This fibrosis narrows or...